INKON Life Technology Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000XF6
CNY
12.53
0.14 (1.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,882.78
1,556.92
1,468.24
1,155.51
1,089.70
1,027.15
571.61
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,882.78
1,556.92
1,468.24
1,155.51
1,089.70
1,027.15
571.61
Raw Material Cost
1,406.74
1,184.85
1,079.26
861.01
840.94
759.77
353.18
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
482.21
428.82
414.52
364.14
337.46
291.78
157.25
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.03
12.87
8.62
9.08
19.27
20.09
31.20
Selling and Distribution Expenses
225.66
199.84
204.32
161.46
156.84
146.86
121.62
Other Expenses
-45.64
-39.04
-37.45
-34.59
-32.79
-29.49
-17.74
Total Expenditure (Excl Depreciation)
1,679.25
1,435.95
1,332.22
1,049.81
1,026.64
923.63
485.82
Operating Profit (PBDIT) excl Other Income
203.5
121
136
105.7
63.099999999999994
103.5
85.8
Other Income
18.90
52.25
10.74
8.10
80.51
138.92
10.74
Operating Profit (PBDIT)
339.50
268.42
235.65
177.39
215.41
296.70
152.88
Interest
21.03
12.87
8.62
9.08
19.27
20.09
31.20
Exceptional Items
-46.05
-6.19
-7.64
-668.60
-452.29
-24.71
-733.42
Gross Profit (PBDT)
476.04
372.08
388.98
294.50
248.76
267.39
218.43
Depreciation
120.77
100.10
87.87
64.89
68.43
50.87
52.91
Profit Before Tax
151.64
149.27
131.52
-565.19
-324.58
201.03
-664.64
Tax
64.29
33.28
32.32
30.65
31.75
51.29
27.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
68.54
115.42
100.44
-595.92
-364.08
148.52
-703.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
68.54
115.42
100.44
-595.92
-364.08
148.52
-703.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
18.81
0.56
-1.24
0.08
7.75
1.21
10.98
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
87.35
115.99
99.20
-595.84
-356.33
149.74
-692.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
0.0
Reserves
2,512.33
2,430.58
1,381.67
1,283.09
1,773.58
2,596.57
1,338.34
Earnings per share (EPS)
0.09
0.18
0.16
-0.93
-0.57
0.25
0.0
Diluted Earnings per share
0.09
0.18
0.16
-0.93
-0.57
0.25
0.0
Operating Profit Margin (Excl OI)
10.61%
7.46%
9.33%
9.03%
6.1%
10.41%
15.61%
Gross Profit Margin
14.47%
16.02%
14.94%
-43.3%
-23.51%
24.52%
-107.02%
PAT Margin
3.64%
7.41%
6.84%
-51.57%
-33.41%
14.46%
-123.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 20.93% vs 6.04% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -24.66% vs 16.94% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 48.29% vs -3.87% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 62.79% vs 50.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of INKON Life Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,882.78
0
1,882.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,882.78
0
1,882.78
Raw Material Cost
1,406.74
0
1,406.74
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
482.21
0
482.21
Power Cost
0
0
0.00
Manufacturing Expenses
21.03
0
21.03
Selling and Distribution Expenses
225.66
0
225.66
Other Expenses
-45.64
0.00
-45.64
Total Expenditure (Excl Depreciation)
1,679.25
0
1,679.25
Operating Profit (PBDIT) excl Other Income
203.53
0.00
203.53
Other Income
18.90
0
18.90
Operating Profit (PBDIT)
339.50
0
339.50
Interest
21.03
0
21.03
Exceptional Items
-46.05
0
-46.05
Gross Profit (PBDT)
476.04
0
476.04
Depreciation
120.77
0
120.77
Profit Before Tax
151.64
0
151.64
Tax
64.29
0
64.29
Provisions and contingencies
0
0
0.00
Profit After Tax
68.54
0
68.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
68.54
0
68.54
Share in Profit of Associates
0
0
0.00
Minority Interest
18.81
0
18.81
Other related items
0.00
0.00
0.00
Consolidated Net Profit
87.35
0
87.35
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,512.33
0
2,512.33
Earnings per share (EPS)
0.09
0
0.09
Diluted Earnings per share
0.09
0
0.09
Operating Profit Margin (Excl OI)
10.61%
0%
0.00
10.61%
Gross Profit Margin
14.47%
0%
0.00
14.47%
PAT Margin
3.64%
0%
0.00
3.64%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 188.28 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 20.93% vs 6.04% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 8.74 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -24.66% vs 16.94% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.06 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 48.29% vs -3.87% in Dec 2024

Annual - Interest
Interest 2.10 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 62.79% vs 50.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.61%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024